In addition, clinical association analysis showed that positive FOXA1 expression was associated with poor clinicopathological features in patients with gastric cancer, including poor tumor differentiation, large tumor size, and advanced stage of lymph node metastasis. Here, FOXA1 is linked to gastric cancer.